Mesna (Mesnex) Market
Mesna (Mesnex) Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Mesna (Mesnex) Market Size and Growth
The Mesna (Mesnex) market is witnessing growth due to increasing use in oncology for reducing chemotherapy-induced toxicity. The market size is projected to reach approximately $250 million by 2025, driven by rising cancer incidences and the need for effective prophylactic treatments. Competitive dynamics emphasize innovation and strategic partnerships in therapy advancements. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Mylan
◍ Baxter
◍ Teva Pharmaceutical
◍ Fresenius Kabi
◍ Hikma Pharmaceuticals
◍ Gland Pharma Limited
◍ Sagent Pharmaceuticals
◍ Athenex Pharmaceuticals
◍ Jiangsu Hengrui Medicine
The Mesna (Mesnex) market features companies like Mylan, Baxter, and Teva, supplying this chemoprotective agent to mitigate urotoxicity. These firms enhance market growth through product innovation, strategic partnerships, and expanding distribution channels. Their sales revenue contributes significantly, with notable figures including Mylan's $11.29 billion and Teva's $16.1 billion.
Request Sample Report
Market Segmentation
By Application
By Product
Oral
Injections ◍ Hospital Pharmacies ◍ Retail Pharmacies ◍ Online Pharmacies
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
